Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Substance Abuse and Mental Health Services Administration 

# AGENCY:

Substance Abuse and Mental Health Services Administration, HHS. 

# ACTION:

Notice.

# SUMMARY:

                        The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories currently certified to meet the standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the                         **Federal Register**                         on April 11, 1988 (53 FR 11970), and subsequently revised in the                         **Federal Register**                         on June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on April 13, 2004 (69 FR 19644).                     

                        A notice listing all currently certified laboratories is published in the                         **Federal Register**                         during the first week of each month. If any laboratory's certification is suspended or revoked, the laboratory will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines.                     

If any laboratory has withdrawn from the HHS National Laboratory Certification Program (NLCP) during the past month, it will be listed at the end, and will be omitted from the monthly listing thereafter. 

                        This notice is also available on the Internet at                         *http://workplace.samhsa.gov*                         and                         *http://www.drugfreeworkplace.gov.*

# FOR FURTHER INFORMATION CONTACT:

Mrs. Giselle Hersh or Dr. Walter Vogl, Division of Workplace Programs, SAMHSA/CSAP, Room 2-1035, 1 Choke Cherry Road, Rockville, Maryland 20857; (240) 276-2600 (voice), (240) 276-2610 (fax). 

# SUPPLEMENTARY INFORMATION:

The Mandatory Guidelines were developed in accordance with Executive Order 12564 and section 503 of Public Law 100-71. Subpart C of the Mandatory Guidelines, “Certification of Laboratories Engaged in Urine Drug Testing for Federal Agencies,” sets strict standards that laboratories must meet in order to conduct drug and specimen validity tests on urine specimens for Federal agencies. To become certified, an applicant laboratory must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory must participate in a quarterly performance testing program plus undergo periodic, on-site inspections. 

Laboratories which claim to be in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A laboratory must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA) which attests that it has met minimum standards. 

                    In accordance with Subpart C of the Mandatory Guidelines dated April 13, 2004 (69 FR 19644), the following laboratories meet the minimum                           ( print page 59357)                        standards to conduct drug and specimen validity tests on urine specimens:                 

ACL Laboratories 

8901 W. Lincoln Ave. 

West Allis, WI 53227 

414-328-7840/800-877-7016 

(Formerly: Bayshore Clinical Laboratory). 

ACM Medical Laboratory, Inc. 

160 Elmgrove Park 

Rochester, NY 14624 

585-429-2264.

Advanced Toxicology Network 

3560 Air Center Cove, Suite 101 

Memphis, TN 38118 

901-794-5770/888-290-1150.

Aegis Analytical Laboratories, Inc. 

345 Hill Ave. 

Nashville, TN 37210 

615-255-2400.

Baptist Medical Center-Toxicology Laboratory 

9601 I-630, Exit 7 

Little Rock, AR 72205-7299 

501-202-2783 

(Formerly: Forensic Toxicology Laboratory Baptist Medical Center).

Clinical Reference Lab 

8433 Quivira Road 

Lenexa, KS 66215-2802 

800-445-6917.

Diagnostic Services, Inc., dba DSI 

12700 Westlinks Drive 

Fort Myers, FL 33913 

239-561-8200/800-735-5416.

Doctors Laboratory, Inc. 

2906 Julia Drive 

Valdosta, GA 31602 

229-671-2281.

DrugScan, Inc. 

P.O. Box 2969 

1119 Mearns Road 

Warminster, PA 18974 

215-674-9310.

Dynacare Kasper Medical Laboratories* 

10150-102 St., Suite 200 

Edmonton, Alberta 

Canada T5J 5E2 

780-451-3702/800-661-9876.

ElSohly Laboratories, Inc. 

5 Industrial Park Drive 

Oxford, MS 38655 

662-236-2609.

Express Analytical Labs 

3405 7th Ave., Suite 106 

Marion, IA 52302 

319-377-0500.

Gamma-Dynacare Medical Laboratories* 

A Division of the Gamma-Dynacare 

Laboratory Partnership 

245 Pall Mall Street 

London, ONT, Canada N6A 1P4 

519-679-1630.

General Medical Laboratories 

36 South Brooks St. 

Madison, WI 53715 

608-267-6225.

LabOne, Inc. 

10101 Renner Blvd. 

Lenexa, KS 66219 

913-888-3927/800-873-8845 

(Formerly: Center for Laboratory Services, a Division of LabOne, Inc.).

Laboratory Corporation of America Holdings 

7207 N. Gessner Road 

Houston, TX 77040 

713-856-8288/800-800-2387.

Laboratory Corporation of America Holdings 

69 First Ave. 

Raritan, NJ 08869 

908-526-2400/800-437-4986 

(Formerly: Roche Biomedical Laboratories, Inc.).

Laboratory Corporation of America Holdings 

1904 Alexander Drive 

Research Triangle Park, NC 27709 

919-572-6900/800-833-3984 

(Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group).

Laboratory Corporation of America Holdings 

10788 Roselle St. 

San Diego, CA 92121 

800-882-7272 

(Formerly: Poisonlab, Inc.).

Laboratory Corporation of America Holdings 

550 17th Ave., Suite 300 

Seattle, WA 98122 

206-923-7020 / 800-898-0180 

(Formerly: DrugProof, Division of Dynacare/Laboratory of Pathology, LLC; Laboratory of Pathology of Seattle, Inc.; DrugProof, Division of Laboratory of Pathology of Seattle, Inc.).

Laboratory Corporation of America Holdings 

1120 Main Street 

Southaven, MS 38671 

866-827-8042 / 800-233-6339 

(Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center).

Marshfield Laboratories 

Forensic Toxicology Laboratory 

1000 North Oak Ave. 

Marshfield, WI 54449 

715-389-3734 / 800-331-3734.

MAXXAM Analytics Inc.* 

6740 Campobello Road 

Mississauga, ON 

Canada L5N 2L8 

905-817-5700 

(Formerly: NOVAMANN (Ontario), Inc.).

MedTox Laboratories, Inc. 

402 W. County Road D 

St. Paul, MN 55112 

651-636-7466 / 800-832-3244.

MetroLab-Legacy Laboratory Services 

1225 NE 2nd Ave. 

Portland, OR 97232 

503-413-5295 / 800-950-5295.

Minneapolis Veterans Affairs Medical Center 

Forensic Toxicology Laboratory 

1 Veterans Drive 

Minneapolis, MN 55417 

612-725-2088.

National Toxicology Laboratories, Inc. 

1100 California Ave. 

Bakersfield, CA 93304 

661-322-4250 / 800-350-3515.

Northwest Toxicology, a LabOne Company 

2282 South Presidents Drive, Suite C 

West Valley City, UT 84120 

801-606-6301 / 800-322-3361 

(Formerly: LabOne, Inc., dba Northwest Toxicology; NWT Drug Testing, NorthWest Toxicology, Inc.; Northwest Drug Testing, a division of NWT Inc.).

One Source Toxicology Laboratory, Inc. 

1213 Genoa-Red Bluff 

Pasadena, TX 77504 

888-747-3774 

(Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory).

Oregon Medical Laboratories 

P.O. Box 972 

722 East 11th Ave. 

Eugene, OR 97440-0972 

541-687-2134.

Pacific Toxicology Laboratories 

9348 DeSoto Ave. 

Chatsworth, CA 91311 

800-328-6942 

(Formerly: Centinela Hospital Airport Toxicology Laboratory).

Pathology Associates Medical Laboratories 

110 West Cliff Dr. 

Spokane, WA 99204 

509-755-8991 / 800-541-7897x7.

Physicians Reference Laboratory 

7800 West 110th St. 

Overland Park, KS 66210 

913-339-0372 / 800-821-3627.

Quest Diagnostics Incorporated 

3175 Presidential Dr. 

Atlanta, GA 30340 

770-452-1590 / 800-729-6432 

(Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories).

Quest Diagnostics Incorporated 

4770 Regent Blvd. 

                    Irving, TX 75063                           ( print page 59358)    

800-824-6152 

(Moved from the Dallas location on 03/31/01; Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories).

Quest Diagnostics Incorporated 

4230 South Burnham Ave., Suite 250 

Las Vegas, NV 89119-5412 

702-733-7866 / 800-433-2750 

(Formerly: Associated Pathologists Laboratories, Inc.).

Quest Diagnostics Incorporated 

400 Egypt Road 

Norristown, PA 19403 

610-631-4600 / 877-642-2216 

(Formerly: SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories).

Quest Diagnostics Incorporated 

506 E. State Pkwy. 

Schaumburg, IL 60173 

800-669-6995 / 847-885-2010 

(Formerly: SmithKline Beecham Clinical Laboratories; International Toxicology Laboratories).

Quest Diagnostics Incorporated 

7600 Tyrone Ave. 

Van Nuys, CA 91405 

818-989-2520 / 800-877-2520 

(Formerly: SmithKline Beecham Clinical Laboratories).

Scientific Testing Laboratories, Inc. 

450 Southlake Blvd. 

Richmond, VA 23236 

804-378-9130.

Sciteck Clinical Laboratories, Inc. 

317 Rutledge Road 

Fletcher, NC 28732 

828-650-0409 

S.E.D. Medical Laboratories 

5601 Office Blvd. 

Albuquerque, NM 87109 

505-727-6300 / 800-999-5227.

South Bend Medical Foundation, Inc. 

530 N. Lafayette Blvd. 

South Bend, IN 46601 

574-234-4176 x276.

Southwest Laboratories 

4645 E. Cotton Center Boulevard 

Suite 177 

Phoenix, AZ 85040 

602-438-8507 / 800-279-0027.

Sparrow Health System 

Toxicology Testing Center, St. Lawrence Campus 

1210 W. Saginaw 

Lansing, MI 48915 

517-364-7400 

(Formerly: St. Lawrence Hospital & Healthcare System).

St. Anthony Hospital Toxicology Laboratory 

1000 N. Lee St. 

Oklahoma City, OK 73101 

405-272-7052.

Toxicology & Drug Monitoring Laboratory

University of Missouri Hospital & Clinics 

301 Business Loop 70 West, Suite 208 

Columbia, MO 65203 

573-882-1273.

Toxicology Testing Service, Inc. 

5426 N.W. 79th Ave. 

Miami, FL 33166 

305-593-2260.

US Army Forensic Toxicology Drug Testing Laboratory 

2490 Wilson St. 

Fort George G. Meade, MD 20755-5235 

                    301-677-7085.                                    

As a result of hurricane Katrina, the following laboratory's certification is suspended because extensive damage to the New Orleans area has prevented the laboratory from testing specimens and fully participating in the National Laboratory Certification Program:

Kroll Laboratory Specialists, Inc. 

1111 Newton St. 

Gretna, LA 70053 

504-361-8989 / 800-433-3823 

(Formerly: Laboratory Specialists, Inc.). 

Anna Marsh, 

Director, Office Program Services, SAMHSA. 

# Footnotes

* The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS' NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. 

                        Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (                        **Federal Register**                        , July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the                         **Federal Register**                         on April 13, 2004 (69 FR 19644). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program.                     
        Back to Citation      

[FR Doc. 05-20488 Filed 10-11-05; 8:45 am] 

BILLING CODE 4160-20-U